Summit X’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Summit X's BLUE Position: Q2 2025 in Review
Summit X sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 25,045 shares — an estimated $122K sold.
Summit X first reported a position in BLUE in Q3 2022 and held it in 10 quarters. The position peaked at $732K in Q2 2023. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Summit X reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Summit X sold 25,045 bluebird bio shares in Q2 2025, an estimated $122K.
- Summit X first reported a position in bluebird bio in Q3 2022 and held it in 10 quarters.
- Summit X's bluebird bio position peaked at $732K in Q2 2023.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Summit X's 13F filing for Q2 2025, filed 7 Aug 2025.